Grifols, S.A.

Contributing Author

Recent Articles by Grifols, S.A.

Aug-10	Grifols Announces Last Patient Last Visit in SPARTA, its Phase 3 Outcomes Study of Prolastin-C in Patients With Emphysema Due to Alpha-1 Antitrypsin Deficiency GRFS GlobeNewswire
Jul-16	Grifols Doses First Patients in Two Phase 3 Trials to Expand Indications of its Flagship Immunoglobulins GRFS GlobeNewswire
Jun-15	Grifols Launches FESILTY (fibrinogen, human-chmt) in the U.S. GRFS GlobeNewswire
Mar-17	Grifols Shares Results From its Chronos Platform Identifying Early Molecular Changes Associated with Parkinson's Disease GRFS GlobeNewswire